Back to search results

Open-label Single-arm Study to Assess the Efficacy of Mirikizumab in Patients With Inflammatory Strictures Due to CD

Abroad (travel likely)RecruitingPHASE4

Conditions

Crohn Disease

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

  • Digestive & Liver Center of Florida, Orlando, Florida, United States

    Contact: Study coordinator (Harinath Sheela, Dr) · hsheela@dlcfl.com

  • Velocity Clinical- Salt Lake City, Salt Lake City, Utah, United States

  • GI Institute Research Foundation, Vancouver, British Columbia, Canada

    Contact: Study coordinator (Brian Bressler) · brian_bressler@hotmail.com
    Contact: Principal Investigator (Brian Bressler, Dr)

  • London Digestive Disease Institute, London, Ontario, Canada

  • The Office of Dr. Jason Reinglas, Scarborough Village, Ontario, Canada

    Contact: Study coordinator (Jason Reinglas)
    Contact: Principal Investigator (Jason Reinglas, Dr)
View source on ClinicalTrials.gov(opens in a new tab)